Filing Details
- Accession Number:
- 0001214659-24-011963
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 15:18:06
- Reporting Period:
- 2024-07-02
- Accepted Time:
- 2024-07-03 15:18:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682639 | Eyenovia Inc. | EYEN | Pharmaceutical Preparations (2834) | 471178401 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1783415 | M. Stuart Grant | 11 Summit Lane Greenville DE 19807 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Acquisiton | 2024-07-02 | 1,515,151 | $0.66 | 10,914,153 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants to purchase common stock | Acquisiton | 2024-07-02 | 3,264,931 | $0.00 | 3,264,931 | $0.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,942,361 | 2025-01-01 | 2030-01-01 | No | 4 | J | Direct |
Footnotes
- The purchase price per share for the common stock set forth above is the combined purchase price for each share of common stock, together with a warrant to purchase one share of common stock issued pursuant to a securities stock purchase agreement among the Company, the Reporting Person and other purchasers (the "Securities Purchase Agreement")
- In connection with the Securities Purchase Agreement, the Reporting Person also received a total of 3,264,931 warrants to purchase common stock at an exercise price of $0.69 per share (consisting of 1,515,151 warrants issued together with the shares purchased and an additional 1,749,780 warrants) and had the exercise price of all of his previously issued warrants (consisting of 677,430 warrants) reduced to $0.69 per share and the expiration date thereof extended to January 1, 2030.
- Includes 3,942,361 shares of common stock issuable upon exercise of all warrants currently owned by the Reporting Person
Billionaire Hedge Funds
